MyFinsight
Home
Blog
About
Contact
Download
Download image
Product
$201,308K
License
$3,610K
Revenue
$204,918K
Operating income
$34,795K
Total costs and
expenses
$170,123K
Net income before
taxes
$20,363K
Total other expense
-$14,432K
Other income
$2,387K
Total selling,
general and...
$88,217K
Total research and
development
$48,396K
Cost of revenue
$33,510K
Net income
$19,777K
Income tax expense
$586K
Loss on
extinguishment of debt
-$9,153K
Interest expense
$7,666K
Other selling,
general and...
$73,142K
Stock-based compensation
$15,075K
Other research and
development
$43,521K
Stock-based compensation
$4,875K
Back
Back
Income Statement
TG Therapeutics BRIUMVI Approval Call Slide Deck 12
TG THERAPEUTICS, INC. (TGTX)
TG Therapeutics BRIUMVI Approval Call Slide Deck 12
TG THERAPEUTICS, INC. (TGTX)
source: myfinsight.com